October 2023– date –

There are two distinct topics concerning GLP-1 receptor agonists (Ozempic®, Wegovy®, Mounjaro®, and others) and the eyes: (1) a temporary worsening (early worsening) of diabetic retinopathy that accompanies a rapid improvement in blood g...